Molecular cues guiding inflammatory responses
- PMID: 20053659
- DOI: 10.1093/cvr/cvq001
Molecular cues guiding inflammatory responses
Abstract
Alarm signals generated at inflammatory foci reach the vascular lumen to attract immune cells towards the affected tissue. Different leucocyte subsets decipher and integrate these complex signals in order to make adequate decisions for their migration towards the inflamed tissue. Soluble cues (cytokines and chemokines) and membrane receptors in both endothelium and leucocytes orchestrate the coordinated recruitment of specific inflammatory cell subsets. All these molecules are spatio-temporally organized in specialized structures at the luminal side of endothelium and the leucocyte membrane or are generated as chemical gradients in the damaged tissue. Thus, the repertoire of chemokines and their receptors as well as adhesion molecules expressed by each leucocyte subset determine their recruitment for participation in specific inflammatory pathologies. Whenever inflammatory signals are altered or misprocessed, inflammation can become chronic, causing extensive tissue damage. To combat chronic inflammation and autoimmune diseases, novel therapeutic strategies attempt to silence the predominant signals in each inflammatory scenario. In this review, we provide a general overview of all these aspects related to the molecular regulation of leucocyte guidance in inflammatory responses.
Similar articles
-
Chemokines in the vascular inflammatory response of atherosclerosis.Cardiovasc Res. 2010 May 1;86(2):192-201. doi: 10.1093/cvr/cvp391. Epub 2009 Dec 9. Cardiovasc Res. 2010. PMID: 20007309 Review.
-
Spotlight on mechanisms of vascular inflammation.Cardiovasc Res. 2010 May 1;86(2):171-3. doi: 10.1093/cvr/cvq083. Epub 2010 Mar 13. Cardiovasc Res. 2010. PMID: 20228399 No abstract available.
-
Molecular regulators of leucocyte chemotaxis during inflammation.Cardiovasc Res. 2010 May 1;86(2):183-91. doi: 10.1093/cvr/cvq040. Epub 2010 Feb 2. Cardiovasc Res. 2010. PMID: 20124403 Review.
-
ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration.Cardiovasc Res. 2010 May 1;86(2):283-92. doi: 10.1093/cvr/cvq050. Epub 2010 Feb 17. Cardiovasc Res. 2010. PMID: 20164118
-
Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.Circulation. 2007 Aug 14;116(7):764-73. doi: 10.1161/CIRCULATIONAHA.107.695189. Epub 2007 Aug 6. Circulation. 2007. PMID: 17679613
Cited by
-
Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway.Oncotarget. 2016 Jul 19;7(29):44975-44990. doi: 10.18632/oncotarget.10455. Oncotarget. 2016. PMID: 27391444 Free PMC article.
-
Anti-inflammatory therapy for diabetic retinopathy.Immunotherapy. 2011 May;3(5):609-28. doi: 10.2217/imt.11.24. Immunotherapy. 2011. PMID: 21554091 Free PMC article. Review.
-
Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.Evid Based Complement Alternat Med. 2012;2012:982396. doi: 10.1155/2012/982396. Epub 2012 Feb 13. Evid Based Complement Alternat Med. 2012. PMID: 22454693 Free PMC article.
-
An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration.BMC Biol. 2018 Mar 6;16(1):29. doi: 10.1186/s12915-018-0489-4. BMC Biol. 2018. PMID: 29510700 Free PMC article.
-
Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.Int J Vasc Med. 2012;2012:918267. doi: 10.1155/2012/918267. Epub 2012 Feb 12. Int J Vasc Med. 2012. PMID: 22611498 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources